Document is current
Any future updates will be listed below
-
Authors
Iyer, Vishakh https://orcid.org/0000-0002-6827-3166
Vo, Quynh
Mell, Anthony
Chinniah, Siven
Zenerovitz, Ashley
Venkiteswaran, Kala
Kunselman, Allen R.
Fang, Jidong
Subramanian, Thyagarajan
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS42402)
U.S. Department of Health & Human Services | NIH | National Center for Complementary and Integrative Health (R21AT001607)
U.S. Department of Health & Human Services | Health Resources and Services Administration (DIBTH0632)
Grace Woodward Fund, Anne M and Phillip Gladfelter III Foundation and the Pennsylvania Tobacco Settlement Funds Biomedical Research Grant
American Parkinson Disease Association
Barsumian Trust Grant
- License Information
-
More Information
Article History
Received: 15 April 2019
Accepted: 21 October 2019
First Online: 29 November 2019
Competing interests
: T.S. is a speaker board member and scientific advisory board member at Teva, Acadia, Acorda, Adamas, USMedWorlds, and Neurocrine. He has received research funding for clinical trials in which he served as site PI from Intec, Adamas, Allergan, Pharma 2B, and Eli Lily. These activities do not represent any competing interests regarding the publication of this paper. The remaining authors declare no competing interests.
